Veterans trial aims for Drug-Free remission in blood cancer
NCT ID NCT06520098
Summary
This study is for veterans with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who are already taking a standard pill (BTKi). It tests if adding a second drug, venetoclax, for one year leads to better results than continuing the standard pill alone. After the year, all drugs are stopped, and doctors monitor if the cancer stays controlled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LYMPHOCYTIC LEUKEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Durham VA Medical Center, Durham, NC
RECRUITINGDurham, North Carolina, 27705-3875, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Kansas City VA Medical Center, Kansas City, MO
RECRUITINGKansas City, Missouri, 64128-2226, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
San Francisco VA Medical Center, San Francisco, CA
RECRUITINGSan Francisco, California, 94121-1563, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
VA Puget Sound Health Care System Seattle Division, Seattle, WA
RECRUITINGSeattle, Washington, 98108-1532, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.